Pathstone Family Office, LLC Repligen Corp Transaction History
Pathstone Family Office, LLC
- $15.6 Billion
- Q3 2023
A detailed history of Pathstone Family Office, LLC transactions in Repligen Corp stock. As of the latest transaction made, Pathstone Family Office, LLC holds 5,641 shares of RGEN stock, worth $771,181. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,641
Previous 4,087
38.02%
Holding current value
$771,181
Previous $578,000
55.02%
% of portfolio
0.01%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding RGEN
# of Institutions
496Shares Held
53.9MCall Options Held
420KPut Options Held
85.3K-
Black Rock Inc. New York, NY7.57MShares$1.03 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.07MShares$693 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.61MShares$630 Million0.07% of portfolio
-
State Street Corp Boston, MA1.74MShares$238 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA1.42MShares$194 Million0.55% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.59B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....